Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTO-genotype dependent weight reduction with bromocriptine in obese patients
DRKS00003349Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Oct 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Bromocriptine with Placebo (2 arms). Started Oct 2012; status: completed.
02
Drugs
bromocriptine
03
Conditions
obesity
Beyond the preview
Go deeper on DRKS00003349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003349.